{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T06:27:31Z","timestamp":1785824851170,"version":"3.56.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,9,16]]},"DOI":"10.7759\/cureus.18013","type":"journal-article","created":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T10:51:38Z","timestamp":1631789498000},"source":"Crossref","is-referenced-by-count":15,"title":["Insulin Resistance, Hyperandrogenism, and Its Associated Symptoms Are the Precipitating Factors for Depression in Women With Polycystic Ovarian Syndrome"],"prefix":"10.7759","author":[{"given":"Aarthi","family":"Ethirajulu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Almothana","family":"Alkasabera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chike B","family":"Onyali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Comfort","family":"Anim-Koranteng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hira E","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitin","family":"Bhawnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihan A","family":"Mostafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/nu13020520","article-title":"Hypothalamic inflammation as a potential pathophysiologic basis for the heterogeneity of clinical, hormonal, and metabolic presentation in PCOS","volume":"13","author":"Barlampa D","year":"2021","unstructured":"Barlampa D, Bompoula MS, Bargiota A, Kalantaridou S, Mastorakos G, Valsamakis G. Hypothalamic inflammation as a potential pathophysiologic basis for the heterogeneity of clinical, hormonal, and metabolic presentation in PCOS. Nutrients. 2021, 13:520. 10.3390\/nu13020520","journal-title":"Nutrients"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dex044","article-title":"High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis","volume":"32","author":"Cooney LG","year":"2017","unstructured":"Cooney LG, Lee I, Sammel MD, Dokras A. High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod. 2017, 32:1075-91. 10.1093\/humrep\/dex044","journal-title":"Hum Reprod"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2147\/IJWH.S145383","article-title":"Psychological burden among women with polycystic ovarian syndrome in Oman: a case-control study","volume":"9","author":"Sulaiman MA","year":"2017","unstructured":"Sulaiman MA, Al-Farsi YM, Al-Khaduri MM, Waly MI, Saleh J, Al-Adawi S. Psychological burden among women with polycystic ovarian syndrome in Oman: a case-control study. Int J Womens Health. 2017, 9:897-904. 10.2147\/IJWH.S145383","journal-title":"Int J Womens Health"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1089\/met.2010.0039","article-title":"Polycystic ovary syndrome in the pediatric population","volume":"8","author":"Bremer AA","year":"2010","unstructured":"Bremer AA. Polycystic ovary syndrome in the pediatric population. Metab Syndr Relat Disord. 2010, 8:375-94. 10.1089\/met.2010.0039","journal-title":"Metab Syndr Relat Disord"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2018.05.004","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"110","author":"Teede HJ","year":"2018","unstructured":"Teede HJ, Misso ML, Costello MF, et al.. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Fertil Steril. 2018, 110:364-79. 10.1016\/j.fertnstert.2018.05.004","journal-title":"Fertil Steril"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-030562","article-title":"Quality of life, psychosocial well-being, and sexual satisfaction in women with polycystic ovary syndrome","volume":"88","author":"Elsenbruch S","year":"2003","unstructured":"Elsenbruch S, Hahn S, Kowalsky D, Offner AH, Schedlowski M, Mann K, Janssen OE. Quality of life, psychosocial well-being, and sexual satisfaction in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2003, 88:5801-7. 10.1210\/jc.2003-030562","journal-title":"J Clin Endocrinol Metab"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1177\/147323000803600604","article-title":"The relationship between clinico-biochemical characteristics and psychiatric distress in young women with polycystic ovary syndrome","volume":"36","author":"Adali E","year":"2008","unstructured":"Adali E, Yildizhan R, Kurdoglu M, et al.. The relationship between clinico-biochemical characteristics and psychiatric distress in young women with polycystic ovary syndrome. J Int Med Res. 2008, 36:1188-96. 10.1177\/147323000803600604","journal-title":"J Int Med Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2011.09.024","article-title":"Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE\/ASRM-Sponsored 3rd PCOS Consensus Workshop Group","volume":"97","author":"Fauser BC","year":"2012","unstructured":"Fauser BC, Tarlatzis BC, Rebar RW, et al.. Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE\/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril. 2012, 97:28-38.e25. 10.1016\/j.fertnstert.2011.09.024","journal-title":"Fertil Steril"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dms029","article-title":"Emotional distress is a common risk in women with polycystic ovary syndrome: a systematic review and meta-analysis of 28 studies","volume":"18","author":"Veltman-Verhulst SM","year":"2012","unstructured":"Veltman-Verhulst SM, Boivin J, Eijkemans MJ, Fauser BJ. Emotional distress is a common risk in women with polycystic ovary syndrome: a systematic review and meta-analysis of 28 studies. Hum Reprod Update. 2012, 18:638-51. 10.1093\/humupd\/dms029","journal-title":"Hum Reprod Update"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/s0277-9536(01)00034-x","article-title":"'The thief of womanhood': women's experience of polycystic ovarian syndrome","volume":"54","author":"Kitzinger C","year":"2002","unstructured":"Kitzinger C, Willmott J. 'The thief of womanhood': women's experience of polycystic ovarian syndrome. Soc Sci Med. 2002, 54:349-61. 10.1016\/s0277-9536(01)00034-x","journal-title":"Soc Sci Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-2430","article-title":"Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome","volume":"91","author":"Lo JC","year":"2006","unstructured":"Lo JC, Feigenbaum SL, Yang J, Pressman AR, Selby JV, Go AS. Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome. J Clin Endocrinol Metab. 2006, 91:1357-63. 10.1210\/jc.2005-2430","journal-title":"J Clin Endocrinol Metab"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp1514916","article-title":"Clinical practice. Polycystic ovary syndrome","volume":"375","author":"McCartney CR","year":"2016","unstructured":"McCartney CR, Marshall JC. Clinical practice. Polycystic ovary syndrome. N Engl J Med. 2016, 375:54-64. 10.1056\/NEJMcp1514916","journal-title":"N Engl J Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.12740\/PP\/OnlineFirst\/93105","article-title":"Psychiatric disorders in women with polycystic ovary syndrome","volume":"53","author":"Rodriguez-Paris D","year":"2019","unstructured":"Rodriguez-Paris D, Remlinger-Molenda A, Kurzawa R, et al.. Psychiatric disorders in women with polycystic ovary syndrome. Psychiatr Pol. 2019, 53:955-66. 10.12740\/PP\/OnlineFirst\/93105","journal-title":"Psychiatr Pol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2018.03.009","article-title":"Insulin resistance is associated with depression risk in polycystic ovary syndrome","volume":"110","author":"Greenwood EA","year":"2018","unstructured":"Greenwood EA, Pasch LA, Cedars MI, Legro RS, Eisenberg E, Huddleston HG. Insulin resistance is associated with depression risk in polycystic ovary syndrome. Fertil Steril. 2018, 110:27-34. 10.1016\/j.fertnstert.2018.03.009","journal-title":"Fertil Steril"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/der338","article-title":"Depression, anxiety and cardiometabolic risk in polycystic ovary syndrome","volume":"26","author":"Cinar N","year":"2011","unstructured":"Cinar N, Kizilarslanoglu MC, Harmanci A, Aksoy DY, Bozdag G, Demir B, Yildiz BO. Depression, anxiety and cardiometabolic risk in polycystic ovary syndrome. Hum Reprod. 2011, 26:3339-45. 10.1093\/humrep\/der338","journal-title":"Hum Reprod"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dml017","article-title":"The origins and sequelae of abnormal neuroendocrine function in polycystic ovary syndrome","volume":"12","author":"Blank SK","year":"2006","unstructured":"Blank SK, McCartney CR, Marshall JC. The origins and sequelae of abnormal neuroendocrine function in polycystic ovary syndrome. Hum Reprod Update. 2006, 12:351-61. 10.1093\/humupd\/dml017","journal-title":"Hum Reprod Update"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2019.06.018","article-title":"Body-image distress is increased in women with polycystic ovary syndrome and mediates depression and anxiety","volume":"112","author":"Alur-Gupta S","year":"2019","unstructured":"Alur-Gupta S, Chemerinski A, Liu C, Lipson J, Allison K, Sammel MD, Dokras A. Body-image distress is increased in women with polycystic ovary syndrome and mediates depression and anxiety. Fertil Steril. 2019, 112:930-938.e1. 10.1016\/j.fertnstert.2019.06.018","journal-title":"Fertil Steril"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.4103\/IJPSYM.IJPSYM_561_17","article-title":"Anxiety, depression, and quality of life in women with polycystic ovarian syndrome","volume":"40","author":"Chaudhari AP","year":"2018","unstructured":"Chaudhari AP, Mazumdar K, Mehta PD. Anxiety, depression, and quality of life in women with polycystic ovarian syndrome. Indian J Psychol Med. 2018, 40:239-46. 10.4103\/IJPSYM.IJPSYM_561_17","journal-title":"Indian J Psychol Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2008.09.018","article-title":"Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society","volume":"92","author":"Moran LJ","year":"2009","unstructured":"Moran LJ, Pasquali R, Teede HJ, Hoeger KM, Norman RJ. Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society. Fertil Steril. 2009, 92:1966-82. 10.1016\/j.fertnstert.2008.09.018","journal-title":"Fertil Steril"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-2350","article-title":"Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline","volume":"98","author":"Legro RS","year":"2013","unstructured":"Legro RS, Arslanian SA, Ehrmann DA, Hoeger KM, Murad MH, Pasquali R, Welt CK. Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2013, 98:4565-92. 10.1210\/jc.2013-2350","journal-title":"J Clin Endocrinol Metab"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2006.11.039","article-title":"Increased risk of depressive disorders in women with polycystic ovary syndrome","volume":"87","author":"Hollinrake E","year":"2007","unstructured":"Hollinrake E, Abreu A, Maifeld M, Van Voorhis BJ, Dokras A. Increased risk of depressive disorders in women with polycystic ovary syndrome. Fertil Steril. 2007, 87:1369-76. 10.1016\/j.fertnstert.2006.11.039","journal-title":"Fertil Steril"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2019-00234","article-title":"Depression over the lifespan in a population-based cohort of women with polycystic ovary syndrome: longitudinal analysis","volume":"104","author":"Greenwood EA","year":"2019","unstructured":"Greenwood EA, Yaffe K, Wellons MF, Cedars MI, Huddleston HG. Depression over the lifespan in a population-based cohort of women with polycystic ovary syndrome: longitudinal analysis. J Clin Endocrinol Metab. 2019, 104:2809-19. 10.1210\/jc.2019-00234","journal-title":"J Clin Endocrinol Metab"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007506.pub2","article-title":"Lifestyle changes in women with polycystic ovary syndrome","author":"Moran LJ","year":"2011","unstructured":"Moran LJ, Hutchison SK, Norman RJ, Teede HJ. Lifestyle changes in women with polycystic ovary syndrome. Cochrane Database Syst Rev. 2011, CD007506. 10.1002\/14651858.CD007506.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016-1896","article-title":"Weight loss and lowering androgens predict improvements in health-related quality of life in women with PCOS","volume":"101","author":"Dokras A","year":"2016","unstructured":"Dokras A, Sarwer DB, Allison KC, et al.. Weight loss and lowering androgens predict improvements in health-related quality of life in women with PCOS. J Clin Endocrinol Metab. 2016, 101:2966-74. 10.1210\/jc.2016-1896","journal-title":"J Clin Endocrinol Metab"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-019-0480-x","article-title":"Vitamin D and probiotic co-supplementation affects mental health, hormonal, inflammatory and oxidative stress parameters in women with polycystic ovary syndrome","volume":"12","author":"Ostadmohammadi V","year":"2019","unstructured":"Ostadmohammadi V, Jamilian M, Bahmani F, Asemi Z. Vitamin D and probiotic co-supplementation affects mental health, hormonal, inflammatory and oxidative stress parameters in women with polycystic ovary syndrome. J Ovarian Res. 2019, 12:5. 10.1186\/s13048-019-0480-x","journal-title":"J Ovarian Res"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2018.03.028","article-title":"Cognitive-behavioral therapy improves weight loss and quality of life in women with polycystic ovary syndrome: a pilot randomized clinical trial","volume":"110","author":"Cooney LG","year":"2018","unstructured":"Cooney LG, Milman LW, Hantsoo L, et al.. Cognitive-behavioral therapy improves weight loss and quality of life in women with polycystic ovary syndrome: a pilot randomized clinical trial. Fertil Steril. 2018, 110:161-171.e1. 10.1016\/j.fertnstert.2018.03.028","journal-title":"Fertil Steril"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.11343","article-title":"Role of bupropion and naltrexone in managing depression with polycystic ovary syndrome: a case report and literature review","volume":"12","author":"Shah K","year":"2020","unstructured":"Shah K, Kulkarni R, Singh R, Pannu HS, Kamrai D. Role of bupropion and naltrexone in managing depression with polycystic ovary syndrome: a case report and literature review. Cureus. 2020, 12:e11343. 10.7759\/cureus.11343","journal-title":"Cureus"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.22074\/ijfs.2019.5703","article-title":"Stress, depression, sexual function, and alexithymia in infertile females with and without polycystic ovary syndrome: a case-control study","volume":"13","author":"Basirat Z","year":"2019","unstructured":"Basirat Z, Faramarzi M, Esmaelzadeh S, Abedi Firoozjai SH, Mahouti T, Geraili Z. Stress, depression, sexual function, and alexithymia in infertile females with and without polycystic ovary syndrome: a case-control study. Int J Fertil Steril. 2019, 13:203-8. 10.22074\/ijfs.2019.5703","journal-title":"Int J Fertil Steril"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0233876","article-title":"Long-term effects of a three-component lifestyle intervention on emotional well-being in women with polycystic ovary syndrome (PCOS): A secondary analysis of a randomized controlled trial","volume":"15","author":"Jiskoot G","year":"2020","unstructured":"Jiskoot G, Dietz de Loos A, Beerthuizen A, Timman R, Busschbach J, Laven J. Long-term effects of a three-component lifestyle intervention on emotional well-being in women with polycystic ovary syndrome (PCOS): A secondary analysis of a randomized controlled trial. PLoS One. 2020, 15:e0233876. 10.1371\/journal.pone.0233876","journal-title":"PLoS One"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/65250-insulin-resistance-hyperandrogenism-and-its-associated-symptoms-are-the-precipitating-factors-for-depression-in-women-with-polycystic-ovarian-syndrome","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:31:49Z","timestamp":1707507109000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/65250-insulin-resistance-hyperandrogenism-and-its-associated-symptoms-are-the-precipitating-factors-for-depression-in-women-with-polycystic-ovarian-syndrome"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,16]]},"references-count":29,"URL":"https:\/\/doi.org\/10.7759\/cureus.18013","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9,16]]}}}